We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
If thin, translucent or white-to-yellow proteinaceous strands (1–2 mm in length) are visible, filtration is advised.
Albumin-bound paclitaxel formulations for infusion (nab-paclitaxel; brand names Abraxane, Pazenir) differ from conventional paclitaxel medicines in their authorised indications, pharmacokinetics, recommended dosages, and preparation and administration instructions. Healthcare professionals should use caution when prescribing, dispensing, preparing, and administering any paclitaxel...
A summary of recent letters and notifications sent to healthcare professionals about medicines and medical devices.
Neon Healthcare Ltd is recalling the specific batch mentioned in this notification as a precautionary measure.
Check the tariff classification for surface-active preparation for washing the skin and the hair (gel 2-in-1).
Find out how to make fertiliser from processed ABPs including bonemeal, and if you need approval to manufacture, store or transport it.
Applications received to amend the specification of a patent under sections 27 and 75 before the court and the Office.
Launched in January 2024, IRP aims to further help bring life-saving new medicines to UK patients without delay
Examples of viral haemorrhagic fevers (VHFs) include Lassa fever, Crimean-Congo haemorrhagic fever, Marburg and Ebola virus diseases.
The management, surveillance and epidemiology of carbapenem resistance.
Healthcare professionals prescribing montelukast should be alert to the risk of neuropsychiatric reactions in all patients including children and adolescents. Reported neuropsychiatric reactions include sleep disorders, hallucinations, anxiety and depression, as well as changes in behaviour and mood. Healthcare professionals...
Details of the process changes for established medicines, effective from 1 March 2024, which apply specifically to chemical products.
An overview of the process including submitting or fast tracking an application, naming your medicine and paying fees.
Check the tariff classification for antimicrobial bathing systems.
Check the tariff classification for components in sets for dental repair.
Export controls on goods that can be used for torture or capital punishment.
Check timescales for the Legal Aid Agency (LAA) to process your work (eg prior authority application, graduated fee claims).
Get help to classify plastics for import and export.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. We’ll send you a link to a feedback form. It will take only 2 minutes to fill in. Don’t worry we won’t send you spam or share your email address with anyone.